Ushering in the Era of Synthetic Virology: EnCapsid Therapeutics Introduces a New Dimension in AAV Engineering to Boost Infectivity and Reduce Immunogenicity in Animal Models
/PRNewswire/ -- EnCapsid Therapeutics Inc., the pioneer in synthetic virology, has obtained results to show that its modular and versatile capsid modification...